Molecule2Market Pty Ltd
Website: http://molecule2market.com.au/
Member Contact: Anne De Luca
Position: Director
Industry: R&D Services
Company Profile:
Established in 2012, Molecule2Market (M2M) is a boutique CRO dedicated to advancing Australia’s contribution to the research and development of innovative medical treatments. Each with over 15 years’ experience the M2M team provides high quality services across all phases of clinical research and a broad range of therapeutic areas across Australia and New Zealand. In addition, we are uniquely placed to support our geographically diverse clients through our US office.
M2M services cover all aspects of clinical research including:
· Project feasibility
· Site selection
· Study start-up (ethics/regulatory submissions, contract negotiation)
· Project Management
· Monitoring
· Safety reporting
· Quality review/ Audit
M2M also offers the following services:
· Regulatory
· Data Management/ Statistics
· Medical Writing
· Medical Monitoring
· Local study sponsorship
· Support Australian R&D Tax Incentive
M2M is a proud member of the Association of International Contract Research Organizations (AICROS) - an alliance of local established CROs providing high quality clinical research services on a global scale.
